Cargando…
The PKC-β selective inhibitor, Enzastaurin, impairs memory in middle-aged rats
Enzastaurin is a Protein Kinase C-β selective inhibitor that was developed to treat cancers. Protein Kinase C-β is an important enzyme for a variety of neuronal functions; in particular, previous rodent studies have reported deficits in spatial and fear-conditioned learning and memory with lower lev...
Autores principales: | Willeman, Mari N., Mennenga, Sarah E., Siniard, Ashley L., Corneveaux, Jason J., De Both, Matt, Hewitt, Lauren T., Tsang, Candy W. S., Caselli, Jason, Braden, B. Blair, Bimonte-Nelson, Heather A., Huentelman, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988320/ https://www.ncbi.nlm.nih.gov/pubmed/29870545 http://dx.doi.org/10.1371/journal.pone.0198256 |
Ejemplares similares
-
The GABA(A) antagonist bicuculline attenuates progesterone-induced memory impairments in middle-aged ovariectomized rats
por: Braden, B. Blair, et al.
Publicado: (2015) -
Combination Treatments with the PKC Inhibitor, Enzastaurin, Enhance the Cytotoxicity of the Anti-Mesothelin Immunotoxin, SS1P
por: Mattoo, Abid R., et al.
Publicado: (2013) -
A Frame-Shift Mutation in CAV1 Is Associated with a Severe Neonatal Progeroid and Lipodystrophy Syndrome
por: Schrauwen, Isabelle, et al.
Publicado: (2015) -
Molecular pathways involved in the synergistic interaction of the PKCβ inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells
por: Tekle, C, et al.
Publicado: (2008) -
Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
por: Huentelman, Matt, et al.
Publicado: (2019)